Results 101 to 110 of about 9,092 (211)

Clin Microbiol Newsl [PDF]

There are several new hot topics in antifungals and antifungal susceptibility testing. In this review, four topics of general interest to the clinical microbiology community are discussed.

core  

Intravenous Solution Wastage in Hospital Pharmacy at Baptist Memorial Hospital-North Mississippi (Oxford) [PDF]

, 2017
Introduction: IV solution wastage refers to IV medications made for a patient that remain unused by that patient for a variety of reasons, and have subsequently expired, or for other reasons cannot be used for another patient (recycled), and therefore ...
Zhang, Yujing
core   +1 more source

Impact of Candida species colonization and azoles resistance in a neonatal intensive care unit [PDF]

, 2017
Background: Candida species are among the top 10 most frequently isolated nosocomial bloodstream pathogens in Europe. In particular, in neonatal intensive care units (NICUs) Candida infections are an emerging concern because of the increasing incidence ...
Corsello, G., Geraci, D., Giuffre, M., Graziano, G., Insinga, V., Maida, C., Saporito, L., Torregrossa, M., Vecchio, D., Vitale, F.   +9 more
core  

Comparison of antifungal drugs in the treatment of invasive pulmonary aspergillosis: a systematic review and network meta-analysis

Frontiers in Microbiology
BackgroundVoriconazole, isavuconazole, and amphotericin (AmB) formulations are currently recommended to treat invasive pulmonary aspergillosis (IPA).
Jing Cheng, Hedong Han, Wenwen Kang, Zijin Cai, Ping Zhan, Tangfeng Lv   +5 more
doaj   +1 more source

Anidulafungin is a useful surrogate marker for predicting in vitro susceptibility to rezafungin among five Candida species using CLSI methods and interpretive criteria

Journal of Clinical Microbiology
This study addresses the use of other echinocandins as surrogate markers to predict the susceptibility of rezafungin against the six most common Candida spp.
Marisa L. Winkler, Lalitagauri Deshpande, John H. Kimbrough, Maura Karr, Paul Rhomberg, Abby L. Klauer, Mariana Castanheira   +6 more
doaj   +1 more source

Dynamics of Anidulafungin use in a Tertiary Care Hospital [PDF]

Journal of Clinical and Diagnostic Research, 2014
Zeliha Kocak Tufan, Rahmet Guner, Tumer Guven, Gul Ruhsar Yilmaz, Mehmet A. Tasyaran   +4 more
doaj   +1 more source

Anidulafungin and its role in candida infections

Infection and Drug Resistance, 2009
Diane M Cappelletty, Rose JungThe University of Toledo, College of Pharmacy, Toledo, OH, USAAbstract: Candida infections continue to play a significant role not only in critically ill and immunocompromised patients but also in non-compromised patients ...
Diane M Cappelletty, Rose Jung
doaj  

DP042 | IMPACT OF ANTIFUNGAL PROPHYLAXIS ON TRANSPLANT-RELATED MORTALITY IN MISMATCHED ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT): A PROSPECTIVE EXPERIENCE FROM A SINGLE TRANSPLANT PROGRAM

Haematologica
Background In the allogeneic HSCT, the incidence of Invasive Fungal Disease is 7-9% with high rate of mortality. Although the antifungal prophylaxis is crucial, the role of anidulafungin is unknown.
A. Carobene, M. Pedata, M. Celentano, T. Ascione, C. Riccardi, S. Marotta, S. Leone, I. Migliaccio, C. Luise, U. De Martino, V. Oliva, S.M. Muggianu, M. Boccola, D. Buonanno, C. Falco, L. Altomare, A. Zuccarelli, M. Toriello, R. Penta, and A. Picardi   +19 more
doaj  

Evaluation of the Synergistic Activity of Anidulafungin with Isavuconazole, Voriconazole, Posaconazole, and Amphotericin B in <i>Candida auris</i> (<i>Candidozyma auris</i>) Isolates. [PDF]

Infect Drug Resist
Turan D, Sarmis A, Adaleti R, Aksaray S.
europepmc   +1 more source

A Calcineurin Inhibitor as an Enhancer of <i>Candida</i> Susceptibility to Anidulafungin. [PDF]

ACS Omega
Rovira I, Montemayor E, Gil-Alonso S, Miranda-Cadena K, Sanchez-Reus F, Quindós G, Eraso E, Jauregizar N.   +7 more
europepmc   +1 more source